Masataka Katashima Selected Research

ASP2151

12/2017	Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies.
12/2017	The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies.
11/2017	Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults.
8/2016	Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes.
1/2014	Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masataka Katashima Research Topics

Disease

4	Neoplasms (Cancer) 04/2013 - 01/2007
3	Body Weight (Weight, Body) 01/2020 - 08/2006
3	Infections 12/2017 - 01/2007
3	Overactive Urinary Bladder (Overactive Bladder) 12/2016 - 01/2014
3	Mycoses (Diseases, Fungus) 01/2007 - 08/2006
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 01/2020
2	Herpes Zoster 12/2017 - 11/2017
2	Herpes Genitalis (Genital Herpes) 08/2016 - 01/2014
2	Aspergillosis 01/2007 - 04/2006
1	Pulmonary Arterial Hypertension 06/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 06/2021
1	Rheumatoid Arthritis 01/2020
1	Anemia 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Secondary Hyperparathyroidism 04/2018
1	Tyrosinemias (Tyrosinemia) 12/2015
1	Melanoma (Melanoma, Malignant) 04/2013
1	Prostatic Neoplasms (Prostate Cancer) 04/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2007
1	Candidiasis (Moniliasis) 04/2006

Drug/Important Bio-Agent (IBA)

5	ASP2151IBA 12/2017 - 01/2014
3	mirabegronIBA 12/2016 - 01/2014
3	sepantroniumIBA 04/2013 - 09/2012
3	Micafungin (FK463)FDA Link 08/2006 - 04/2006
2	Quetiapine Fumarate (Seroquel)FDA Link 01/2020 - 01/2020
2	SurvivinIBA 04/2013 - 09/2012
1	beraprostIBA 06/2021
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 06/2021
1	Janus Kinase InhibitorsIBA 01/2020
1	Delayed-Action PreparationsIBA 01/2020
1	peficitinibIBA 01/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	roxadustatIBA 01/2019
1	CarbonIBA 01/2019
1	Prolyl-Hydroxylase InhibitorsIBA 01/2019
1	Parathyroid Hormone (Parathormone)IBA 04/2018
1	ASP7991IBA 04/2018
1	Calcium-Sensing ReceptorsIBA 04/2018
1	DNA Primase (Primase)IBA 12/2017
1	Tolterodine Tartrate (Detrol)FDA Link 12/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2016
1	IsoenzymesIBA 12/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 12/2016
1	Pharmaceutical PreparationsIBA 08/2016
1	nitisinone (Orfadin)FDA Link 12/2015
1	CreatinineIBA 04/2013
1	Hormones (Hormone)IBA 04/2013
1	Alanine Transaminase (SGPT)IBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 09/2012
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2007
1	EchinocandinsIBA 08/2006

Therapy/Procedure

5	Therapeutics 01/2014 - 08/2006
1	Oral Administration 01/2020
1	Organ Transplantation 01/2007